Molecular biology reports · 2026
Evaluation of 18 S rRNA as an endogenous control in OpenArray® plasma RNA qPCR workflows.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Francis Habib, Januszewski Andrzej S, Mangani Abubakar, Ema Fahmida K, Hardikar Anandwardhan A, Joglekar Mugdha V, Huang Michael L H, Sullivan David R, Ma Ronald C W, Galande Sanjeev, Gebski Val, Simes R John, Jenkins Alicia J, Molloy Mark P, Keech Anthony C
Аннотация
BACKGROUND: Reliable qPCR analysis depends on stable endogenous controls, particularly in high-throughput pre-amplification workflows where technical bias may arise. The suitability of highly abundant 18 S rRNA as a reference gene in multiplex OpenArray® platforms remains debated. This study evaluated the stability of 18 S rRNA, its impact on co-amplified targets, and comparability between archived and newly manufactured primer pools.
METHODS: Plasma RNA from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) trial was analysed using TaqMan OpenArray® following reverse transcription and pre-amplification. Paired samples (n = 23) were pre-amplified with primer pools with and without 18 S rRNA and compared across four target genes. Stability of 18 S rRNA was assessed in 789 samples across 17 runs. Agreement between archived and new primer pools was evaluated in 774 paired samples using Wilcoxon signed-rank and Bland-Altman analyses.
RESULTS: 18 S rRNA showed stable detection (median Ct 14.5, IQR 13.4-16.3) with low inter-run variability (CV 3.9%). Inclusion of 18 S rRNA during pre-amplification did not significantly alter Ct values of co-amplified targets (median differences 0.07-0.52 cycles; p > 0.05), with minimal overall bias (-0.18 Ct). Archived and newly manufactured primer pools showed a small but significant Ct shift, with lower values in the new pool (bias 0.53 Ct; p < 0.0001), although variability between paired measurements was wide.
CONCLUSION: 18 S rRNA is a stable technical control in plasma OpenArray® workflows and did not measurably bias co-amplified targets during pre-amplification. Archived and new primer pools showed only minor systematic differences and remained broadly comparable at the group level.
METHODS: Plasma RNA from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) trial was analysed using TaqMan OpenArray® following reverse transcription and pre-amplification. Paired samples (n = 23) were pre-amplified with primer pools with and without 18 S rRNA and compared across four target genes. Stability of 18 S rRNA was assessed in 789 samples across 17 runs. Agreement between archived and new primer pools was evaluated in 774 paired samples using Wilcoxon signed-rank and Bland-Altman analyses.
RESULTS: 18 S rRNA showed stable detection (median Ct 14.5, IQR 13.4-16.3) with low inter-run variability (CV 3.9%). Inclusion of 18 S rRNA during pre-amplification did not significantly alter Ct values of co-amplified targets (median differences 0.07-0.52 cycles; p > 0.05), with minimal overall bias (-0.18 Ct). Archived and newly manufactured primer pools showed a small but significant Ct shift, with lower values in the new pool (bias 0.53 Ct; p < 0.0001), although variability between paired measurements was wide.
CONCLUSION: 18 S rRNA is a stable technical control in plasma OpenArray® workflows and did not measurably bias co-amplified targets during pre-amplification. Archived and new primer pools showed only minor systematic differences and remained broadly comparable at the group level.